BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 25600959)

  • 1. Forkhead box protein P3 (Foxp3) expression serves as an early chronic inflammation marker of squamous cell differentiation and aggressive pathology of urothelial carcinomas in neurological patients.
    Phé V; Rouprêt M; Cussenot O; Chartier-Kastler E; Gamé X; Compérat E
    BJU Int; 2015 Apr; 115 Suppl 6():28-32. PubMed ID: 25600959
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel markers of squamous differentiation in the urinary bladder.
    Huang W; Williamson SR; Rao Q; Lopez-Beltran A; Montironi R; Eble JN; Grignon DJ; Idrees MT; Emerson RE; Zhou XJ; Zhang S; Baldridge LA; Hahn NM; Wang M; Koch MO; Cheng L
    Hum Pathol; 2013 Oct; 44(10):1989-97. PubMed ID: 23806524
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Micropapillary variant of urothelial carcinoma of the urinary bladder; a clinicopathological and immunohistochemical study.
    Samaratunga H; Khoo K
    Histopathology; 2004 Jul; 45(1):55-64. PubMed ID: 15228444
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does presence of squamous and glandular differentiation in urothelial carcinoma of the bladder at cystectomy portend poor prognosis? An intensive case-control analysis.
    Mitra AP; Bartsch CC; Bartsch G; Miranda G; Skinner EC; Daneshmand S
    Urol Oncol; 2014 Feb; 32(2):117-27. PubMed ID: 23477878
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduced CD151 expression is related to advanced tumour stage in urothelial bladder cancer.
    Minner S; De Silva C; Rink M; Dahlem R; Chun F; Fisch M; Höppner W; Wagner W; Bokemeyer C; Terracciano L; Simon R; Sauter G; Wilczak W
    Pathology; 2012 Aug; 44(5):448-52. PubMed ID: 22772340
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumour infiltrating CD25+ FoxP3+ regulatory T cells (Tregs) relate to tumour grade and stromal inflammation in oral squamous cell carcinoma.
    Al-Qahtani D; Anil S; Rajendran R
    J Oral Pathol Med; 2011 Sep; 40(8):636-42. PubMed ID: 21352381
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective immunohistochemical markers to distinguish between metastatic high-grade urothelial carcinoma and primary poorly differentiated invasive squamous cell carcinoma of the lung.
    Gruver AM; Amin MB; Luthringer DJ; Westfall D; Arora K; Farver CF; Osunkoya AO; McKenney JK; Hansel DE
    Arch Pathol Lab Med; 2012 Nov; 136(11):1339-46. PubMed ID: 23106579
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of tumour FoxP3 as prognostic marker in different subtypes of head and neck cancer.
    Weller P; Bankfalvi A; Gu X; Dominas N; Lehnerdt GF; Zeidler R; Lang S; Brandau S; Dumitru CA
    Eur J Cancer; 2014 May; 50(7):1291-300. PubMed ID: 24630394
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclooxygenase-2 expression on urothelial and inflammatory cells of cystoscopic biopsies and urine cytology as a possible predictive marker for bladder carcinoma.
    Moussa M; Omran Z; Nosseir M; Lotfy A; Swellam T
    APMIS; 2009 Jan; 117(1):45-52. PubMed ID: 19161536
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Invasive micropapillary urothelial carcinoma of the bladder.
    Lopez-Beltran A; Montironi R; Blanca A; Cheng L
    Hum Pathol; 2010 Aug; 41(8):1159-64. PubMed ID: 20381120
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of the endothelin axis in noninvasive and superficially invasive bladder cancer: relation to clinicopathologic and molecular prognostic parameters.
    Eltze E; Wild PJ; Wülfing C; Zwarthoff EC; Burger M; Stoehr R; Korsching E; Hartmann A
    Eur Urol; 2009 Nov; 56(5):837-45. PubMed ID: 18945538
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Squamous differentiation in primary urothelial carcinoma of the urinary tract as seen by MAC387 immunohistochemistry.
    Lopez-Beltran A; Requena MJ; Alvarez-Kindelan J; Quintero A; Blanca A; Montironi R
    J Clin Pathol; 2007 Mar; 60(3):332-5. PubMed ID: 16882698
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Investigations on the clinical significance of FOXP3 protein expression in cervical oesophageal cancer and the number of FOXP3+ tumour-infiltrating lymphocytes.
    Xia M; Zhao MQ; Wu K; Lin XY; Liu Y; Qin YJ
    J Int Med Res; 2013 Aug; 41(4):1002-8. PubMed ID: 23760912
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation of pathological grade and tumor stage of urothelial carcinomas with CD109 expression.
    Hagikura M; Murakumo Y; Hasegawa M; Jijiwa M; Hagiwara S; Mii S; Hagikura S; Matsukawa Y; Yoshino Y; Hattori R; Wakai K; Nakamura S; Gotoh M; Takahashi M
    Pathol Int; 2010 Nov; 60(11):735-43. PubMed ID: 20946523
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Accurate preoperative prediction of non-organ-confined bladder urothelial carcinoma at cystectomy.
    Green DA; Rink M; Hansen J; Cha EK; Robinson B; Tian Z; Chun FK; Tagawa S; Karakiewicz PI; Fisch M; Scherr DS; Shariat SF
    BJU Int; 2013 Mar; 111(3):404-11. PubMed ID: 22805163
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of cytokeratin 20 redefines urothelial papillomas of the bladder.
    Harnden P; Mahmood N; Southgate J
    Lancet; 1999 Mar; 353(9157):974-7. PubMed ID: 10459907
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Divergent differentiation in urothelial carcinoma and other bladder cancer subtypes with selected mimics.
    Shanks JH; Iczkowski KA
    Histopathology; 2009 Jun; 54(7):885-900. PubMed ID: 19178589
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pseudoangiosarcomatous urothelial carcinoma of the urinary bladder.
    Paner GP; Cox RM; Richards K; Akki A; Gokden N; Lopez-Beltran A; Krausz T; McKenney JK; Steinberg GD
    Am J Surg Pathol; 2014 Sep; 38(9):1251-9. PubMed ID: 25133708
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transient receptor potential vanilloid type 2 (TRPV2) expression in normal urothelium and in urothelial carcinoma of human bladder: correlation with the pathologic stage.
    Caprodossi S; Lucciarini R; Amantini C; Nabissi M; Canesin G; Ballarini P; Di Spilimbergo A; Cardarelli MA; Servi L; Mammana G; Santoni G
    Eur Urol; 2008 Sep; 54(3):612-20. PubMed ID: 17977643
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The lymphatic system in clinically localized urothelial carcinoma of the bladder: morphologic characteristics and predictive value.
    Bolenz C; Auer M; Ströbel P; Heinzelbecker J; Schubert C; Trojan L
    Urol Oncol; 2013 Nov; 31(8):1606-14. PubMed ID: 22503575
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.